| abstract |
The present invention relates to a compound selected from the group consisting of a compound of formula (I), a dimeric form thereof, a pharmaceutically acceptable ester and a salt thereof. Such compounds are useful as inhibitors or metalloproteases such as zinc proteases, especially zinc hydrolase, and are effective in treating disease states associated with increased incidence of vasoconstriction:n n n Formula In n n n n n n n Wheren n n R 1 , R 2 , A, X and m are as defined in the specification and claims. |